Merck & Company Inc (MRK)vsSonida Senior Living Inc (SNDA)
MRK
Merck & Company Inc
$143.93
-0.54%
HEALTHCARE · Cap: $355.10B
SNDA
Sonida Senior Living Inc
$39.52
-0.65%
HEALTHCARE · Cap: $1.81B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 13738% more annual revenue ($66.57B vs $481.07M). MRK leads profitability with a 4.8% profit margin vs -25.4%. SNDA appears more attractively valued with a PEG of 2.04. SNDA earns a higher WallStSmart Score of 40/100 (D).
MRK
Hold36
out of 100
Grade: F
SNDA
Hold40
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-73.7%
Fair Value
$82.84
Current Price
$143.93
$61.09 premium
Intrinsic value data unavailable for SNDA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Revenue surging 137.1% year-over-year
Reasonable price relative to book value
Areas to Watch
Trading at 8.5x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Expensive relative to growth rate
Smaller company, higher risk/reward
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : SNDA
The strongest argument for SNDA centers on Revenue Growth, Price/Book. Revenue growth of 137.1% demonstrates continued momentum.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 116.1x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : SNDA
The primary concerns for SNDA are PEG Ratio, Market Cap, Debt/Equity. Debt-to-equity of 1.83 is elevated, increasing financial risk.
Key Dynamics to Monitor
MRK profiles as a value stock while SNDA is a hypergrowth play — different risk/reward profiles.
SNDA carries more volatility with a beta of 0.75 — expect wider price swings.
SNDA is growing revenue faster at 137.1% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Bottom Line
SNDA scores higher overall (40/100 vs 36/100) and 137.1% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Sonida Senior Living Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Sonida Senior Living, Inc. develops, owns, operates and manages senior living communities in the United States. The company is headquartered in Dallas, Texas.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?